The Safety and Efficacy of Administrating DiaPep277® Vaccination in Type 1 Diabetes Patients.
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 23 Mar 2017
At a glance
- Drugs Peptide p277 (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- 19 Mar 2017 Planned primary completion date changed from 1 Aug 2014 to 1 Jan 2016.
- 19 Mar 2017 Planned initiation date changed from 1 Aug 2013 to 1 Jan 2015.
- 19 Mar 2017 Status changed from not yet recruiting to withdrawn prior to enrolment because the manufacturer decided to halt manufacturing the vaccine .